287 related articles for article (PubMed ID: 34348632)
21. Noninvasive imaging markers associated with sudden cardiac death.
van der Bijl P; Delgado V; Bax JJ
Trends Cardiovasc Med; 2016 May; 26(4):348-60. PubMed ID: 26632012
[TBL] [Abstract][Full Text] [Related]
22. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
[TBL] [Abstract][Full Text] [Related]
23. Imaging for risk stratification of sudden cardiac death.
van der Bijl P; Bax JJ
Herzschrittmacherther Elektrophysiol; 2022 Sep; 33(3):261-267. PubMed ID: 35841401
[TBL] [Abstract][Full Text] [Related]
24. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.
Levine YC; Matos J; Rosenberg MA; Manning WJ; Josephson ME; Buxton AE
Heart Rhythm; 2016 Feb; 13(2):490-7. PubMed ID: 26409099
[TBL] [Abstract][Full Text] [Related]
25. Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction.
Rodríguez-Zanella H; Muraru D; Secco E; Boccalini F; Azzolina D; Aruta P; Surkova E; Genovese D; Cavalli G; Sammarco G; Ruozi N; Tenaglia RM; Calvillo-Argüelles O; Palermo C; Iliceto S; Badano LP
JACC Cardiovasc Imaging; 2019 Oct; 12(10):1917-1926. PubMed ID: 30219408
[TBL] [Abstract][Full Text] [Related]
26. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
27. [Factors predisposing to the reprogramming of implantable cardioverter-defibrillators and the causes of changes in pharmacotherapy in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death].
Pudło J; Liszniański P; Senderek T; Lelakowska-Pieła M; Lelakowski J; Nowak J
Pol Merkur Lekarski; 2015 Aug; 39(230):86-90. PubMed ID: 26319381
[TBL] [Abstract][Full Text] [Related]
28. Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.
Pitschner HF; Neuzner J; Himmrich E; Liebrich A; Jung J; Heisel A
J Interv Card Electrophysiol; 1997 Nov; 1(3):211-20. PubMed ID: 9869974
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
[TBL] [Abstract][Full Text] [Related]
30. Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction.
Cannatà A; De Angelis G; Boscutti A; Normand C; Artico J; Gentile P; Zecchin M; Heymans S; Merlo M; Sinagra G
Heart; 2020 May; 106(9):656-664. PubMed ID: 31964657
[TBL] [Abstract][Full Text] [Related]
31. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation.
Klem I; Weinsaft JW; Bahnson TD; Hegland D; Kim HW; Hayes B; Parker MA; Judd RM; Kim RJ
J Am Coll Cardiol; 2012 Jul; 60(5):408-20. PubMed ID: 22835669
[TBL] [Abstract][Full Text] [Related]
32. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
Klein H; Auricchio A; Reek S; Geller C
Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
[TBL] [Abstract][Full Text] [Related]
33. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
Gulati A; Jabbour A; Ismail TF; Guha K; Khwaja J; Raza S; Morarji K; Brown TD; Ismail NA; Dweck MR; Di Pietro E; Roughton M; Wage R; Daryani Y; O'Hanlon R; Sheppard MN; Alpendurada F; Lyon AR; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
JAMA; 2013 Mar; 309(9):896-908. PubMed ID: 23462786
[TBL] [Abstract][Full Text] [Related]
34. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
35. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
[TBL] [Abstract][Full Text] [Related]
36. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].
van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359
[TBL] [Abstract][Full Text] [Related]
37. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
[TBL] [Abstract][Full Text] [Related]
38. Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy.
Akhtar M; Elliott PM
Curr Cardiol Rep; 2019 Nov; 21(12):155. PubMed ID: 31768884
[TBL] [Abstract][Full Text] [Related]
39. Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: implications for identifying patients at risk for sudden cardiac death.
Amit G; Rosenbaum DS; Super DM; Costantini O
Heart Rhythm; 2010 Jun; 7(6):763-8. PubMed ID: 20156592
[TBL] [Abstract][Full Text] [Related]
40. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.
Mikami Y; Jolly U; Heydari B; Peng M; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Lydell CP; Howarth AG; Yee R; White JA
Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28087564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
